Reduced high-density lipoprotein 2b in non-obese type 2 diabetic patients analysed by a microfluidic chip method in a case-control study

Biomarkers. 2009 Dec;14(8):619-23. doi: 10.3109/13547500903204636.

Abstract

Background: Alterations in high-density lipoprotein (HDL) subfractions, especially in the HDL2b subfraction, have been reported in type 2 diabetes mellitus (T2DM). However, new methods for convenient and reliable quantitation of HDL2b are yet to be developed.

Methods: Thirty-eight patients with T2DM were enrolled and age-, sex- and body mass index (BMI)-matched controls were selected from the same population. A microfluidic chip method was employed to analyse serum HDL subfractions.

Results: The microfluidic chip method revealed a significant reduction in HDL2b and its ratio to total HDL in T2DM patients. There was a reverse correlation for total HDL and HDL2b, and its ratio with triglycerides, homeostasis model assessment-insulin sensitivity index (HOMA-IS) and insulin resistance index (HOMA-IR).

Conclusions: We have shown a reduction of HDL2b and its ratio to total HDL by a novel chip method in T2DM patients. The significant correlation between HDL2b and HOMA-IS and HOMA-IR may have further predictive value in clinical utility.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Asian People
  • Blood Glucose / metabolism
  • Body Mass Index
  • Case-Control Studies
  • China
  • Diabetes Mellitus, Type 2 / blood*
  • Female
  • Homeostasis
  • Humans
  • Insulin Resistance
  • Lipoproteins, HDL / blood
  • Lipoproteins, HDL2 / blood*
  • Male
  • Microfluidic Analytical Techniques
  • Middle Aged

Substances

  • Blood Glucose
  • Lipoproteins, HDL
  • Lipoproteins, HDL2